Lin Celia
SEC CIK 1859386 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Chief Medical Off | 11.0K | — | $24.8K | 2 | 2022-08-19 | 2023-08-21 |
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Lin Celia made no open-market trades at VERA in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Lin Celia | Chief Medical Off | S - Sale | $16.65 | -1,490 | 11.0K | -12% | -$24.8K | |
| 2022-08-23 | 2022-08-19 | VERA | Vera Therapeutics, Inc. | Lin Celia | Chief Medical Off | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations